Gene test may help decide how much thyroid to remove in cancer patients
NCT ID NCT06235814
First seen Feb 05, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This pilot study tested whether routine genetic testing of thyroid cancer tumors can help guide surgeons in choosing between removing only part of the thyroid (lobectomy) or the whole gland (total thyroidectomy). Only 2 patients enrolled, so the main goal was to see if a larger future trial is possible. The study focused on patients with papillary thyroid cancer and used a test called Thyroseq to classify tumors as low, intermediate, or high risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLARY THYROID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California Los Angeles
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.